S&P Global has integrated the data from its acquisition of Visible Alpha last year into its Capital IQ Pro platform, allowing its consensus estimates and historical financial data to be combined with ...
Alpha Tau reports promising Alpha DaRT trial results in pancreatic cancer and head and neck cancer, with significant survival benefits. High disease control rate (91% DCR) and positive interim safety ...
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (CSE: ACOG) (“Alpha Cognition” [ACI], or the “Company”), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results